Patent: 6,130,366
✉ Email this page to a colleague
Summary for Patent: 6,130,366
Title: | Chimaeric gene coding for a transit peptide and a heterologous polypeptide |
Abstract: | Chimaeric DNA sequence which encodes: 1) a transmit peptide of a cytoplasmic precursor of a chloroplast protein or polypeptide of a plant and 2) a protein or polypeptide that is heterologous to the transit peptide. The chimaeric DNA sequence can be used as a vector for transforming a plant cell so that a chimaeric precursor of the heterologous protein or polypeptide is produced in the cytoplasm of the cell and the chimaeric precursor then transports the heterologous protein or polypeptide in vivo into a chloroplast of the cell. |
Inventor(s): | Herrera-Estrella; Luis (Ghent, BE), Van Den Broeck; Guidi (Ghent, BE), Van Montagu; Marc (Brussels, BE), Schreier; Peter (Cologne, DE), Schell; Josef (Cologne, DE), Bohnert; Hans J. (Tucson, AZ), Cashomore; Anthony R. (Woodside, NY), Timko; Michael P. (New York, NY), Kausch; Albert P. (Durham, NH) |
Assignee: | Plant Genetic Systems (Gent, BE) Bayer AG (Leverkusen, DE) |
Application Number: | 08/984,151 |
Patent Claims: | see list of patent claims |
Details for Patent 6,130,366
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2004-12-28 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2004-12-28 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2004-12-28 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |